The disordered charged biased proteins in the human diseasome

  • Mouna ChouraEmail author
  • Ahmed Rebaï
Original research article


Intrinsically disordered proteins (IDPs) are often involved in diseases and have been shown to be promising targets for drug development. Here, we focus on the human disordered charged biased proteins (HDCBPs). We have investigated the association of the HDCBPs with diseases by integrating various sources that cover public sources of gene–disease associations and intensive literature mining. The results indicate that 95% of HDCBPs are associated with multiple diseases, including mainly various cancers, nervous, endocrine, immune, hematological, and respiratory systems diseases. Our data show that the HDCBP–disease network constructed by integrating different levels of data together may improve our understanding of these complex diseases. Moreover, we present the top-ranked proteins that might be potential markers for diagnostic and drug targets.


Charged biased proteins Disease association Drugs Therapeutic target 



This work was supported by the Ministry of Higher Education and Scientific Research, Tunisia.

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

Supplementary material

12539_2019_315_MOESM1_ESM.xlsx (510 kb)
Supplemental file: HDCBP–disease associations. It contains in four worksheets. (1) KR proteins including Uniprot ID, number of associated diseases, PubMed IDs, and Opentargets cross-reference. (2) DE proteins including Uniprot ID, number of associated diseases, PubMed IDs, and Opentargets cross-reference. (3) Diseases associated with KR proteins. (4) Diseases associated with DE proteins (XLSX 509 KB)


  1. 1.
    Das S, Pal U, Das S, Bagga K, Roy A, Mrigwani A, Maiti NC (2014) Sequence complexity of amyloidogenic regions in intrinsically disordered human proteins. PLoS One 9(3):e89781CrossRefGoogle Scholar
  2. 2.
    Dosztányi Z, Chen J, Dunker AK, Simon I, Tompa P (2006) Disorder and sequence repeats in hub proteins and their implications for network evolution. J Proteome Res 5:2985–2995CrossRefGoogle Scholar
  3. 3.
    Uversky VN, Dunker AK (2010) Understanding protein non-folding. Biochim Biophys Acta Proteins Proteomics 1804:1231–1264CrossRefGoogle Scholar
  4. 4.
    Tompa P (2011) Unstructural biology coming of age. Curr Opin Struct Biol 21:419–425CrossRefGoogle Scholar
  5. 5.
    Uversky VN (2015) Intrinsically disordered proteins and their (disordered) proteomes in neurodegenerative disorders. Front Aging Neurosci 7:18CrossRefGoogle Scholar
  6. 6.
    Uversky VN, Oldfield CJ, Dunker AK (2008) Intrinsically disordered proteins in human diseases: Introducing the d2 concept. Annu Rev Biophys 37:215–246CrossRefGoogle Scholar
  7. 7.
    DeForte S, Uversky VN (2016) Order, disorder, and everything in between. Molecules 21(8):1090CrossRefGoogle Scholar
  8. 8.
    Goh KI, Cusick ME, Valle D, Childs B, Vidal M, Barabási AL (2007) The human disease network. Proc Natl Acad Sci USA 104:8685–8690CrossRefGoogle Scholar
  9. 9.
    Baranzini SE (2009) The genetics of autoimmune diseases: a networked perspective. Curr Opin Immunol 21:596–605CrossRefGoogle Scholar
  10. 10.
    Ahmed SSSJ, Ahameethunisa AR, Santosh W, Chakravarthy S, Kumar S (2011) Systems biological approach on neurological disorders: a novel molecular connectivity to aging and psychiatric diseases. BMC Syst Biol 5:6CrossRefGoogle Scholar
  11. 11.
    Chan SY, White K, Loscalzo J (2012) Deciphering the molecular basis of human cardiovascular disease through network biology. Curr Opin Cardiol 27:202–209CrossRefGoogle Scholar
  12. 12.
    Choura M, Rebaï A (2013) Exploring charged biased regions in the human proteome. Gene 515:277–280CrossRefGoogle Scholar
  13. 13.
    Choura M, Rebaï A (2017) Exploring disorder in the human charged proteins. J Recept Signal Transduct Res 37:386–390CrossRefGoogle Scholar
  14. 14.
    Carvalho-Silva D, Pierleoni A, Pignatelli M, Ong C, Fumis L, Karamanis N, Carmona M, Faulconbridge A, Hercules A, McAuley E, Miranda A, Peat G, Spitzer M, Barrett J, Hulcoop DG, Papa E, Koscielny G, Dunham I (2018) Open Targets Platform: new developments and updates two years on. Nucleic Acids Res. Google Scholar
  15. 15.
    The Uniprot Consortium (2017) UniProt: the universal protein knowledgebase. Nucleic Acids Res 45(Database issue):D158–D169CrossRefGoogle Scholar
  16. 16.
    Su G, Morris JH, Demchak B, Bader GD (2014) Biological network exploration with Cytoscape 3. Curr Protoc. Google Scholar
  17. 17.
    Johansson S, Leonsson-Zachrisson M, Knutsson M, Spencer AG, Labonté D, Deshpande E, Kohler D, Kozuka J, Charmot K, Rosenbaum DP D (2017) Preclinical and healthy volunteer studies of potential drug–drug interactions between tenapanor and phosphate binders. Clin Pharmacol Drug Dev 6:448–456CrossRefGoogle Scholar
  18. 18.
    Akhter S, Nath SK, Tse CM, Williams J, Zasloff M, Donowitz M (1999) Squalamine, a novel cationic steroid, specifically inhibits the brush-border Na+/H+ exchanger isoform NHE3. Am J Physiol 276(1Pt1):136–144CrossRefGoogle Scholar
  19. 19.
    Dargie HJ, Dollery CT, Daniel J (1977) Minoxidil in resistant hypertension. Lancet 10:515–518CrossRefGoogle Scholar
  20. 20.
    Li M, Marubayashi A, Nakaya Y, Fukui K, Arase S (2001) Minoxidil-induced hair growth is mediated by adenosine in cultured dermal papilla cells: possible involvement of sulfonylurea receptor 2B as a target of minoxidil. J Invest Dermatol 117:1594–1600CrossRefGoogle Scholar

Copyright information

© International Association of Scientists in the Interdisciplinary Areas 2019

Authors and Affiliations

  1. 1.Laboratory of Plant Protection and Improvement, Center of Biotechnology of SfaxUniversity of SfaxSfaxTunisia
  2. 2.Molecular and Cellular Diagnosis Processes, Centre of Biotechnology of SfaxUniversity of SfaxSfaxTunisia

Personalised recommendations